These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 24938375)

  • 1. ALDH1A1 expression correlates with clinicopathologic features and poor prognosis of breast cancer patients: a systematic review and meta-analysis.
    Liu Y; Lv DL; Duan JJ; Xu SL; Zhang JF; Yang XJ; Zhang X; Cui YH; Bian XW; Yu SC
    BMC Cancer; 2014 Jun; 14():444. PubMed ID: 24938375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic significance of ALDH1A1 expression in early invasive breast cancer.
    Althobiti M; El Ansari R; Aleskandarany M; Joseph C; Toss MS; Green AR; Rakha EA
    Histopathology; 2020 Sep; 77(3):437-448. PubMed ID: 32369651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aldehyde dehydrogenase 1A1 expression in breast cancer is associated with stage, triple negativity, and outcome to neoadjuvant chemotherapy.
    Khoury T; Ademuyiwa FO; Chandrasekhar R; Jabbour M; Deleo A; Ferrone S; Wang Y; Wang X
    Mod Pathol; 2012 Mar; 25(3):388-97. PubMed ID: 22080062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ALDH1A1 overexpression is associated with the progression and prognosis in gastric cancer.
    Li XS; Xu Q; Fu XY; Luo WS
    BMC Cancer; 2014 Sep; 14():705. PubMed ID: 25253129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of ALDH1A1 in contributing to breast tumour aggressiveness: A study conducted in an African population.
    Gyan E; Green A; Ahenkorah-Fondjo L; Jackson A; Toss MS; Akakpo PK; Derkyi-Kwarteng L; Rahman GA; Owiredu W
    Ann Diagn Pathol; 2021 Apr; 51():151696. PubMed ID: 33460998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined expression of aldehyde dehydrogenase 1A1 and β-catenin is associated with lymph node metastasis and poor survival in breast cancer patients following cyclophosphamide treatment.
    Sun M; Zhao H; Xiao Q; Yu Z; Song Z; Yao W; Tang H; Guan S; Jin F; Wei M
    Oncol Rep; 2015 Dec; 34(6):3163-73. PubMed ID: 26398662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological significance of ALDH1A1 in lung, colorectal, and breast cancers: a meta-analysis.
    Zhou Y; Wang Y; Ju X; Lan J; Zou H; Li S; Qi Y; Jia W; Hu J; Liang W; Zhang W; Pang L; Li F
    Biomark Med; 2015; 9(8):777-90. PubMed ID: 26230297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of ALDH1A1-positive cancer stem cells in patients with locally advanced, metastasized head and neck squamous cell carcinoma.
    Qian X; Wagner S; Ma C; Coordes A; Gekeler J; Klussmann JP; Hummel M; Kaufmann AM; Albers AE
    J Cancer Res Clin Oncol; 2014 Jul; 140(7):1151-8. PubMed ID: 24770634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations of carboxypeptidase 4 with ALDH1A1 expression and their prognostic value in esophageal squamous cell carcinoma.
    Sun L; Cao J; Guo C; Burnett J; Yang Z; Ran Y; Sun D
    Dis Esophagus; 2017 Jun; 30(6):1-5. PubMed ID: 28475748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low expression of aldehyde dehydrogenase 1A1 (ALDH1A1) is a prognostic marker for poor survival in pancreatic cancer.
    Kahlert C; Bergmann F; Beck J; Welsch T; Mogler C; Herpel E; Dutta S; Niemietz T; Koch M; Weitz J
    BMC Cancer; 2011 Jun; 11():275. PubMed ID: 21708005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are embryonic stem cell markers and ALDH1A1 relevant in the context of breast cancer estrogen positivity?
    Mousa NA; Hussein A; Elemam NM; Mohammed G; Elwany M; Basha T; AlHammadi AA; Majzob RS; Talaat IM
    Cancer Med; 2024 Feb; 13(3):e7004. PubMed ID: 38400679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High ALDH1A1 expression correlates with poor survival in papillary thyroid carcinoma.
    Xing Y; Luo DY; Long MY; Zeng SL; Li HH
    World J Surg Oncol; 2014 Feb; 12():29. PubMed ID: 24485040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-expression of cancer stem cell markers, SALL4/ALDH1A1, is associated with tumor aggressiveness and poor survival in patients with serous ovarian carcinoma.
    Sharbatoghli M; Shamshiripour P; Fattahi F; Kalantari E; Habibi Shams Z; Panahi M; Totonchi M; Asadi-Lari Z; Madjd Z; Saeednejad Zanjani L
    J Ovarian Res; 2022 Jan; 15(1):17. PubMed ID: 35090523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in expression of the cancer stem cell marker aldehyde dehydrogenase 1 among estrogen receptor-positive/human epidermal growth factor receptor type 2-negative breast cancer cases with early, late, and no recurrence.
    Miyoshi Y; Shien T; Ogiya A; Ishida N; Yamazaki K; Horii R; Horimoto Y; Masuda N; Yasojima H; Inao T; Osako T; Takahashi M; Tomioka N; Endo Y; Hosoda M; Doihara H; Miyoshi S; Yamashita H;
    Breast Cancer Res; 2016 Jul; 18(1):73. PubMed ID: 27368476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stem cell biomarker ALDH1A1 in breast cancer shows an association with prognosis and clinicopathological variables that is highly cut-off dependent.
    Sjöström M; Hartman L; Honeth G; Grabau D; Malmström P; Hegardt C; Fernö M; Niméus E
    J Clin Pathol; 2015 Dec; 68(12):1012-9. PubMed ID: 26175266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased expression of ALDH1A1 protein is associated with poor prognosis in clear cell renal cell carcinoma.
    Wang K; Chen X; Zhan Y; Jiang W; Liu X; Wang X; Wu B
    Med Oncol; 2013; 30(2):574. PubMed ID: 23585015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In phyllodes tumour of the breast expression of c-kit but not of ALDH1A1 is associated with adverse clinico-pathological features.
    Chougule A; Bal A; Das A; Kohli PS; Singh G
    Virchows Arch; 2016 Dec; 469(6):651-658. PubMed ID: 27696244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic significance of aldehyde dehydrogenase 1A1 (ALDH1A1) and CD133 expression in early stage non-small cell lung cancer.
    Alamgeer M; Ganju V; Szczepny A; Russell PA; Prodanovic Z; Kumar B; Wainer Z; Brown T; Schneider-Kolsky M; Conron M; Wright G; Watkins DN
    Thorax; 2013 Dec; 68(12):1095-104. PubMed ID: 23878161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aldehyde dehydrogenase 1 expression is correlated with poor prognosis in breast cancer.
    Yao J; Jin Q; Wang XD; Zhu HJ; Ni QC
    Medicine (Baltimore); 2017 Jun; 96(25):e7171. PubMed ID: 28640095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aldehyde dehydrogenase 1 A1-positive cell population is enriched in tumor-initiating cells and associated with progression of bladder cancer.
    Su Y; Qiu Q; Zhang X; Jiang Z; Leng Q; Liu Z; Stass SA; Jiang F
    Cancer Epidemiol Biomarkers Prev; 2010 Feb; 19(2):327-37. PubMed ID: 20142235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.